Comparator: ondansetron IV

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Postoperative Nausea and Vomiting

Phase 3

2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)

CompletedNCT00090246

Merck Sharp & Dohme LLCPostoperative Nausea and Vomiting

Start: 2004-05-13End: 2005-04-20Updated: 2017-05-05

2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)

CompletedNCT00090155

Merck Sharp & Dohme LLCPostoperative Nausea and Vomiting

Start: 2003-09-26End: 2004-11-24Updated: 2017-05-05